Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

SCNX vs COOT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SCNX Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 6–3 Matrix Metrics)

SCNX Overall Winner 6-Pillar Tally: SCNX 3 – 2 COOT (1 Tie) Matrix Metrics: SCNX 6 – 3 COOT

As of Nov 19, 2026, Scienture Holdings, Inc. (SCNX) is the stronger overall head-to-head candidate over Australian Oilseeds Holdings Limited (COOT) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SCNX carries a Unified Composite Score of 53.2/100 (HOLD) at $2.44 (21.8x Forward P/E, -1671.1% operating margin), whereas COOT carries 55.5/100 (HOLD) at $0.34 (N/M Forward P/E, -73.3% operating margin).

  • Composite vs. Pillar Nuance: While COOT currently prints a higher short-term Unified Composite Score (55.5/100 HOLD vs. SCNX 53.2/100 HOLD), SCNX captures the overall institutional head-to-head verdict (6–3 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-1671.1% vs. -73.3% operating margin) and revenue trajectory (+449.1% vs. +9.8% YoY).
  • Technical & Structure Timing Caution: SCNX is currently in a Breakdown options structure phase (RSI 40.1); meanwhile COOT trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 50.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SCNX vs COOT
SCNX NASDAQ Head-to-Head Winner
Scienture Holdings, Inc. Common Stock
Pharmaceutical Preparations
$2.44
-4.51% 1D
Market Cap $4.6M
TTM Revenue $821,315
Forward P/E 21.8x
Beta / 30D Vol 10.87β · 82% Vol
Unified Composite Score
53.2 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 70.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 40
RSI-14: 40.1 · SMA20: $3.07 · SMA50: $2.28
COOT NASDAQ
Australian Oilseeds Holdings Limited Ordinary Shares
Fats & Oils
$0.34
+21.96% 1D
Market Cap $277.8M
TTM Revenue $1.2M
Forward P/E N/M
Beta / 30D Vol -0.03β · 118% Vol
Unified Composite Score
55.5 / 100 HOLD
Tech 65.0 Fund 60.0 Flow 50.0 Mom 70.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 51
RSI-14: 50.7 · SMA20: $0.31 · SMA50: $0.40

6-Pillar Scorecard Institutional Category Breakdown (SCNX 3 – 2 COOT)

Columns: Metric · SCNX · COOT
1. Valuation Multiples SCNX
Forward P/E 21.8x N/M
Trailing P/E 21.8x N/M
PEG Ratio N/M N/M
EV / Revenue 8.6x N/M
2. Growth & Scale SCNX
Revenue Growth (YoY) +449.1% +9.8%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $821,315 $1.2M
Market Cap $4.6M $277.8M
3. Profitability & Quality SCNX
Gross Margin 87.7% 66.2%
Operating Margin -1671.1% -73.3%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) -53.5% -136.4%
4. Balance Sheet & Cash Flow COOT
Cash Generation (TTM) -$12M EBITDA -$512,954 EBITDA
Cash Flow Margin N/A -43.5% EBITDA Mgn
Net Cash / Leverage $2.5M Net Debt (0.17x D/E) $21M Net Debt
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning COOT
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Pharmaceutical Retailers Operator Packaged Foods Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SCNX (6) vs COOT (3)
Institutional Metric SCNX COOT Criterion Row Edge
Market Capitalization
Scale
$4.6M $277.8M Larger Scale COOT
Trailing P/E Ratio
Valuation
21.8x N/M Lower Multiple SCNX
Forward P/E Ratio
Valuation
21.8x N/M Lower Multiple SCNX
Revenue Growth (YoY)
Growth
+449.1% +9.8% Higher Growth SCNX
Operating Margin (TTM)
Profitability
-1671.1% -73.3% Higher Margin COOT
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
-53.5% -136.4% Higher ROE SCNX
52-Week Range Position
Momentum
56% ($0–$4) 11% ($0–$1) Stronger Trend SCNX
Beta / 30D Volatility
Risk Regime
10.87β · 82% Vol -0.03β · 118% Vol Lower Realized Risk SCNX
Unified Institutional Score
Composite Signal
53.2 / 100 (HOLD) 55.5 / 100 (HOLD) Higher Composite COOT
Trailing 12M Revenue (USD)
Operating Scale
$821,315 $1.2M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
87.7% 66.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 8.6x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$12M EBITDA ($2.5M Net Debt (0.17x D/E)) -$512,954 EBITDA ($21M Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SCNX +5.03 pp
SCNX: -16.18% · COOT: -21.21%
3M Horizon SCNX +462.68 pp
SCNX: +441.47% · COOT: -21.21%
6M Horizon SCNX +553.93 pp
SCNX: +508.75% · COOT: -45.18%
1Y Horizon SCNX +355.47 pp
SCNX: +287.74% · COOT: -67.73%

Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant USD Revenue & Operating Margin (%)
Period SCNX Revenue COOT Revenue SCNX Op. Margin COOT Op. Margin Margin Leader
Q4 '24 N/A $40M N/A 0.1% COOT
Q1 '25 N/A $40M N/A -1.4% COOT
Q3 '25 $0M N/A -739.1% N/A SCNX
Q1 '26 $0M N/A -6230.8% N/A SCNX
Q2 '26 $0M N/A -785.6% N/A SCNX

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SCNX BREAKDOWN
28d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SCNX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
COOT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact COOT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SCNX Moat Profile Cyclical / Execution-Driven Positioning
Pharmaceutical Retailers Operator
Competes within the Pharmaceutical Retailers value chain with $4.6M market capitalization and -1671.1% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
COOT Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $277.8M market capitalization and -73.3% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ SCNX vs COOT Key Questions & Quantitative Answers

As of Nov 19, 2026, Scienture Holdings, Inc. (SCNX) is the stronger overall head-to-head candidate over Australian Oilseeds Holdings Limited (COOT) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SCNX carries a Unified Composite Score of 53.2/100 (HOLD) at $2.44 (21.8x Forward P/E, -1671.1% operating margin), whereas COOT carries 55.5/100 (HOLD) at $0.34 (N/M Forward P/E, -73.3% operating margin). Composite vs. Pillar Nuance: While COOT currently prints a higher short-term Unified Composite Score (55.5/100 HOLD vs. SCNX 53.2/100 HOLD), SCNX captures the overall institutional head-to-head verdict (6–3 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-1671.1% vs. -73.3% operating margin) and revenue trajectory (+449.1% vs. +9.8% YoY). Technical & Structure Timing Caution: SCNX is currently in a Breakdown options structure phase (RSI 40.1); meanwhile COOT trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 50.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SCNX leads the Growth & Scale pillar: SCNX posts +449.1% YoY revenue growth and +0.0% YoY earnings growth on $821,315 TTM revenue (87.7% gross margin, -1671.1% operating margin), compared with COOT at +9.8% YoY revenue growth and +0.0% YoY earnings growth on $1.2M TTM revenue (66.2% gross margin, -73.3% operating margin). Across the 5-period historical trajectory (Q4 '24 to Q2 '26), SCNX cumulative revenue shifted N/A while COOT shifted +0.0%. In operating R&D and SG&A reinvestment, SCNX deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for COOT.

SCNX screens cheaper on headline valuation multiples. SCNX trades at 21.8x Forward P/E, 21.8x Trailing P/E, N/M PEG, and 8.6x EV/Revenue (unreported EBITDA margin), whereas COOT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (-43.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SCNX (-53.5% ROE) versus COOT (-136.4% ROE) capital efficiency.

In options market volatility and institutional positioning, SCNX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (10.87β · 82% Vol realized risk). By comparison, COOT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.03β · 118% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.